We are enhancing our smart equipment portfolio with IoT-enabled control systems and cloud connectivity

In an interaction with Express Pharma, Dr Manoj Chaudhari, Managing Director, Mack Pharmatech Pvt. Ltd., highlights the company's focus on digitalisation and compliance-driven innovation, detailing how their next-generation smart stability chambers, cold rooms, and ultra-low freezers are being designed to meet the evolving demands of Pharma 4.0 and advanced therapy applications

- 

What key industry trends are visible at CPHI this year, and how is your company positioning itself in response?

Trend at CPHI:

• The pharma sector is rapidly adopting digitalisation, AI, and IoT— from manufacturing through QC and stability testing.

• Companies are investing in smart, connected lab environments for real-time monitoring, predictive maintenance, and data integrity compliance (especially with FDA 21 CFR Part 11 and EU Annex 11).

• Growth in biologics, cell, and gene therapies is creating new needs for precise temperature and humidity control, especially for biologic sample storage, stability, and transport validation.

Mack Pharmatech's positioning:

• We are enhancing our smart equipment portfolio with integrated data-logging, IoT-enabled control systems, and cloud connectivity.

• Our latest stability chambers and cold rooms feature real-time remote monitoring, automated alarms, and data security features.

• We are collaborating with automation specialists to ensure our products fit seamlessly into digital QC and stability workflows.

• We're developing customised stability and cold-chain simulation systems for biologics and vaccine testing.

• Our ultra-low temperature freezers and precision cold chambers are validated for advanced therapy applications.

• Every Mack Pharmatech system is delivered with comprehensive DQ/IQ/OQ/PQ documentation, traceable calibration, and data-integrity compliant software.

• We've built an internal compliance and validation support team to assist customers during audits and regulatory submissions.

• We are integrating Part 11-compliant digital interfaces for secure audit trails and electronic record management.

How has CPHI influenced your product or market strategy over time?